<?xml version="1.0" encoding="UTF-8"?>
<p>CQ and its analogs have effects against HCV. In particular, the treatment of JFH-1 or Huh-7 cells with CQ reduced HCV entry, replication, and infection in a dose-dependent manner [
 <xref rid="B148-microorganisms-08-00085" ref-type="bibr">148</xref>,
 <xref rid="B149-microorganisms-08-00085" ref-type="bibr">149</xref>,
 <xref rid="B150-microorganisms-08-00085" ref-type="bibr">150</xref>]. Furthermore, CQ, in combination with IFN-α, prevented the replication of HCV and enhanced the antiviral effect of IFN-α [
 <xref rid="B149-microorganisms-08-00085" ref-type="bibr">149</xref>].
</p>
